|
PA24A_BOVIN |
PLA2G4A |
Cytosolic phospholipase A2 |
3.74e-76 |
0.37
|
PTGDS_MOUSE |
Ptgds |
Prostaglandin-H2 D-isomerase |
7.805e-67 |
0.39
|
CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
4.399e-47 |
0.54
|
NRAM2_HUMAN |
SLC11A2 |
Natural resistance-associated macrophage protein 2 |
6.01e-35 |
0.33
|
IMDH_CRYPV |
|
Inosine-5'-monophosphate dehydrogenase |
1.143e-29 |
0.37
|
CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
2.917e-26 |
0.53
|
ALD1_RAT |
Akr1b7 |
Aldo-keto reductase family 1 member B7 |
1.839e-23 |
0.29
|
S1PR3_HUMAN |
S1PR3 |
Sphingosine 1-phosphate receptor 3 |
3.312e-21 |
0.33
|
PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
7.674e-21 |
0.33
|
AK1BA_HUMAN |
AKR1B10 |
Aldo-keto reductase family 1 member B10 |
2.497e-19 |
0.34
|
SMO_MOUSE |
Smo |
Smoothened homolog |
6.389e-18 |
0.40
|
NPC1_HUMAN |
NPC1 |
NPC intracellular cholesterol transporter 1 |
1.11e-16 |
0.32
|
PANK1_HUMAN |
PANK1 |
Pantothenate kinase 1 |
1.11e-15 |
0.30
|
TRPM5_HUMAN |
TRPM5 |
Transient receptor potential cation channel subfamily M member 5 |
3.997e-15 |
0.30
|
Q8RLA6_ACIBA |
blaOXA-33 |
Beta-lactamase |
7.105e-15 |
0.28
|
ADCY5_RAT |
Adcy5 |
Adenylate cyclase type 5 |
4.652e-14 |
0.38
|
PE2R2_HUMAN |
PTGER2 |
Prostaglandin E2 receptor EP2 subtype |
5.729e-14 |
0.35
|
CAC1D_HUMAN |
CACNA1D |
Voltage-dependent L-type calcium channel subunit alpha-1D |
9.504e-14 |
0.30
|
MET_MOUSE |
Met |
Hepatocyte growth factor receptor |
1.704e-13 |
0.29
|
ASAH1_HUMAN |
ASAH1 |
Acid ceramidase |
1.972e-13 |
0.31
|
PER2_HUMAN |
PER2 |
Period circadian protein homolog 2 |
3.778e-13 |
0.30
|
5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
1.6e-12 |
0.34
|
5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
2.061e-12 |
0.34
|
LUCI_AQULA |
|
Luciferin 4-monooxygenase |
4.042e-12 |
0.35
|
PRIO_SHEEP |
PRNP |
Major prion protein |
7.667e-12 |
0.29
|
PTAFR_CAVPO |
PTAFR |
Platelet-activating factor receptor |
7.969e-12 |
0.33
|
EZH2_HUMAN |
EZH2 |
Histone-lysine N-methyltransferase EZH2 |
4.634e-11 |
0.39
|
NPY5R_HUMAN |
NPY5R |
Neuropeptide Y receptor type 5 |
4.867e-11 |
0.35
|
STRP_STRP1 |
ska |
Streptokinase A |
1.229e-10 |
0.62
|
Q533H1_FELCA |
UTS2R |
Urotensin II receptor |
8.861e-10 |
0.31
|
SMCA2_HUMAN |
SMARCA2 |
Probable global transcription activator SNF2L2 |
9.421e-10 |
0.33
|
GRM4_HUMAN |
GRM4 |
Metabotropic glutamate receptor 4 |
1.163e-09 |
0.32
|
TSPO_RAT |
Tspo |
Translocator protein |
2.347e-09 |
0.33
|
PD2R2_HUMAN |
PTGDR2 |
Prostaglandin D2 receptor 2 |
4.37e-09 |
0.35
|
B9W6M3_CANDC |
CNA1 |
Serine/threonine-protein phosphatase |
1.007e-08 |
0.31
|
XBP1_HUMAN |
XBP1 |
X-box-binding protein 1 |
1.382e-08 |
0.49
|
DDIT3_MOUSE |
Ddit3 |
DNA damage-inducible transcript 3 protein |
1.75e-08 |
0.48
|
GRM5_HUMAN |
GRM5 |
Metabotropic glutamate receptor 5 |
4.148e-08 |
0.42
|
LMP1_EBVB9 |
LMP1 |
Latent membrane protein 1 |
6.106e-08 |
0.34
|
M3K5_HUMAN |
MAP3K5 |
Mitogen-activated protein kinase kinase kinase 5 |
6.231e-08 |
0.35
|
Q8T8E9_9TRYP |
galE |
UDP-galactose 4-epimerase |
7.4e-08 |
0.32
|
LIPP_PIG |
PNLIP |
Pancreatic triacylglycerol lipase |
7.513e-08 |
0.29
|
CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
8.583e-08 |
0.51
|
NLRP3_HUMAN |
NLRP3 |
NACHT, LRR and PYD domains-containing protein 3 |
9.216e-08 |
0.41
|
NSMA_RAT |
Smpd2 |
Sphingomyelin phosphodiesterase 2 |
9.613e-08 |
0.30
|
STE24_YEAST |
STE24 |
CAAX prenyl protease 1 |
1.112e-07 |
0.32
|
SMCA4_HUMAN |
SMARCA4 |
Transcription activator BRG1 |
1.239e-07 |
0.33
|
S22A8_HUMAN |
SLC22A8 |
Solute carrier family 22 member 8 |
1.612e-07 |
0.38
|
GYRB_MYCS2 |
gyrB |
DNA gyrase subunit B |
2.358e-07 |
0.31
|
FABPH_HUMAN |
FABP3 |
Fatty acid-binding protein, heart |
3.001e-07 |
0.33
|
TSPO_HUMAN |
TSPO |
Translocator protein |
4.258e-07 |
0.36
|
RAGE_HUMAN |
AGER |
Advanced glycosylation end product-specific receptor |
4.32e-07 |
0.29
|
5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
5.493e-07 |
0.38
|
Q8ST54_TRYCR |
HK |
Phosphotransferase |
6.432e-07 |
0.31
|
NPY5R_RAT |
Npy5r |
Neuropeptide Y receptor type 5 |
6.85e-07 |
0.34
|
5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
7.84e-07 |
0.33
|
ALDR_RAT |
Akr1b1 |
Aldo-keto reductase family 1 member B1 |
7.889e-07 |
0.44
|
KGP1_BOVIN |
PRKG1 |
cGMP-dependent protein kinase 1 |
7.984e-07 |
0.34
|
OXER1_HUMAN |
OXER1 |
Oxoeicosanoid receptor 1 |
9.142e-07 |
0.31
|
PDE10_RAT |
Pde10a |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
1.001e-06 |
0.32
|
RL19A_YEAST |
RPL19A |
60S ribosomal protein L19-A |
1.062e-06 |
0.35
|
ALDR_HUMAN |
AKR1B1 |
Aldo-keto reductase family 1 member B1 |
1.816e-06 |
0.34
|
FABP4_HUMAN |
FABP4 |
Fatty acid-binding protein, adipocyte |
1.851e-06 |
0.33
|
V1AR_MOUSE |
Avpr1a |
Vasopressin V1a receptor |
2.346e-06 |
0.30
|
PLAP_HUMAN |
PLAA |
Phospholipase A-2-activating protein |
2.849e-06 |
0.29
|
GRM5_RAT |
Grm5 |
Metabotropic glutamate receptor 5 |
3.099e-06 |
0.39
|
NORA_STAAU |
norA |
Quinolone resistance protein NorA |
3.728e-06 |
0.29
|
CP26A_HUMAN |
CYP26A1 |
Cytochrome P450 26A1 |
4.496e-06 |
0.32
|
STAT3_HUMAN |
STAT3 |
Signal transducer and activator of transcription 3 |
4.94e-06 |
0.36
|
HSF1_MOUSE |
Hsf1 |
Heat shock factor protein 1 |
5.314e-06 |
0.62
|
SMN_HUMAN |
SMN1; SMN2 |
Survival motor neuron protein |
7.639e-06 |
0.39
|
KCNN3_HUMAN |
KCNN3 |
Small conductance calcium-activated potassium channel protein 3 |
7.679e-06 |
0.30
|
PTAFR_HUMAN |
PTAFR |
Platelet-activating factor receptor |
7.933e-06 |
0.35
|